Every large supplier of medical instruments paid the 2025 tariff
Duty on US imports of medical and surgical instruments went from 0.6% of value to 9.3% in nine months. For chips, the duty sat on China. For instruments, Germany and Japan paid 14%.
If you run supply chain or finance at a device maker, the tariff question for 2025 probably arrived as a China question. Where do our instruments come from, how much of it is China, and how fast can we move it? That framing fits chips, where our own read of the same months found the duty landing almost entirely on Chinese goods.
Instruments did not work that way. We read US Census import data for medical, surgical and dental instruments, customs heading 9018, for January and October 2025, by country of origin. The question was which sources paid duty and how much. Four predictions were written down before the data was pulled.
The duty went from almost nothing to a cost line
Duty as a share of import value on US imports of medical instruments in October 2025: $338.8 million on $3.63 billion of goods in one month. In January 2025 it was 0.6%.
That is the average across every source. The country rows matter more, because they decide what moving supply would actually save.
Effective rate is calculated duty divided by the value of goods entered for consumption, by country of origin. The five largest sources in October 2025 were Mexico, Costa Rica, Germany, Ireland and Japan.
China paid the most, 31.3%, up from 7.4%. But the five largest sources all went from 0.0% to something: Germany to 14.0%, Japan to 13.8%, Ireland to 7.8%, Costa Rica to 6.0% and Mexico to 2.2%. Among every source shipping more than $1 million that month, India paid the highest rate, 46.6%.
Chips and instruments moved in opposite ways
We ran the same read on integrated circuits for the same two months. There, the duty sat almost entirely on China.
Integrated circuits are HS 8542; medical instruments are HS 9018. Same source, same months, same method.
For chips, the average rate in October was 0.9% while China-origin chips paid 60.6%, so moving a chip source out of China removed most of the duty. For instruments, the average was 9.3% and a German or Japanese source paid 14%. Moving an instrument line from China to Germany would cut the duty by roughly half, not to zero.
Three of four predictions held
We expected China’s rate to rise, the overall rate to rise, and China to end above Mexico. All three held. We also expected Mexico to stay under 1% in both months. It did not: it reached 2.2% in October. That is still the lowest rate among the large sources, but the prediction was wrong and it is recorded as a miss.
Two limits sit under all of this. The figures are what importers paid at the border, not who absorbed the cost. And they are two months, not a series: they show the rate rose between January and October, not whether October was typical of the months around it.
- You import instruments under heading 9018, or a heading next to it, and duty is a line in your landed cost.
- You are weighing a move away from China and the savings case assumes the new source pays little or no duty.
- You have your own entries by country of origin, or can get them from your customs broker, to check these averages against your products.
If the move is for supply risk rather than duty, this changes little. If the savings case rests on duty, check the destination country’s rate for your own codes first. For a German or Japanese source, this data says it was not zero in October 2025.
- CEO Duty on instruments rose from 0.6% to 9.3% of import value in nine months, and no large source stayed at zero. Treat duty as a standing cost in sourcing reviews, not a China problem.
- CFO Importers paid $338.8 million in duty on instruments in October 2025 alone. Measure your own landed-cost change by source before repricing anything.
- CRO If the cost passes through, it reaches hospital pricing talks, and many contracts fix prices for a term. Find which contracts allow a duty pass-through before they renew.
- CPO Mexico paid 2.2% in October against Germany’s 14.0%. Price a second source in a lower-duty country against the time it takes to qualify.
- Legal Each country’s rate depends on which tariff actions and trade-agreement claims apply, and this read does not name them. Confirm the legal basis for your own codes before relying on these rates.
- Risk Two months cannot show whether rates are still moving. Read the monthly series through 2026 before committing to a move.
Reconciled. The CEO and CPO seats pull toward moving sources; the CFO and Risk seats pull toward measuring first. The course most of them support: pull your own entries by country for 2025 and 2026, then price a second source in a lower-duty country against its qualification cost. Moving on two months of averages is the one course nearly every seat would object to.
Pull your own duty by country before the next sourcing review.
Ask your customs broker for your 2025 and 2026 entries under heading 9018, by country of origin, with entered value and duty paid. Divide duty by value for each country and month. Compare the result with the rates above, and rebuild the savings case for any planned move on your own numbers.
- What it costs
- A report from your customs broker and a few hours of an analyst’s time. The real cost is a move that may lose its savings case once the destination’s rate is counted.
- How you’ll know
- You have a rate for each source country and month. If the destination’s rate is within a few points of China’s for your codes, the duty case for moving is gone.
Weighing a sourcing move on duty?
A custom Decision Brief takes the decision your team is facing and answers it from sourced, dated evidence, with the limits stated: your headings, your source countries, and the rates they actually paid.
Commission a custom brief Or see the published briefs →